Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds
Recruiting
Phase 1
Interventional Study
Wound Healing
Mohs Micrographic Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 102 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Topical timolol, a β2-Adrenergic receptor (B2AR) antagonist, has demonstrated promise in wound healing over the past several years. The majority of the literature has evaluated the use of topical timolol to shorten wound healing time in chronic wounds of non-surgical etiologies. To date, there are no prospective randomized clinical trials evaluating the role of topical timolol for shortening wound…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be scheduled to undergo MMS at 234 East 85th St for a skin cancer that is deemed Mohs
* Appropriate by the Mohs surgery appropriate use criteria
* Have an open surgical wound \< 4 cm and \> 0.5 cm
* Be ≥18 years of age
* English-speaking
* Provide a signed and dated informed c…
Contacts